NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Net margin 2016–2021
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) net profit margin by fiscal year — reported net income divided by reported revenue.
-250740.0%FY2021 · since FY2016: -474.8% → -250740.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -250740.0% | -240621.0 pp |
| FY2020 | -10119.0% | -5717.0 pp |
| FY2019 | -4402.0% | +327.5 pp |
| FY2018 | -4729.5% | -0.9 pp |
| FY2017 | -4728.5% | -4253.7 pp |
| FY2016 | -474.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice